content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange
  Commission on August 18, 2017</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-</B></P>
  
  <!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: Black 3pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">UNITED
  STATES</P>
  
  <P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SECURITIES
  AND EXCHANGE COMMISSION</P>
  
  <P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">WASHINGTON,
  D.C. 20549</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">FORM S-8</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">REGISTRATION
  STATEMENT</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">UNDER</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">THE SECURITIES
  ACT OF 1933</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADMA BIOLOGICS, INC.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
  its charter)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 45%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 45%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>56-2590442</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of</FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">incorporation or organization)</FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>465 State Route 17</B></FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Ramsey, New Jersey</B></FONT></TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>07446</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Address of Principal Executive Offices)</FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED ADMA BIOLOGICS,
  INC. 2014 OMNIBUS INCENTIVE COMPENSATION PLAN</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 45%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Adam S. Grossman&nbsp;</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
      <TD STYLE="width: 45%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>President and Chief Executive Officer</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>David C. Schwartz, Esq.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>ADMA Biologics, Inc.</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>DLA Piper LLP (US)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>465 State Route 17</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>51 John F. Kennedy Parkway, Suite 120</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Ramsey, New Jersey 07446</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Short Hills, New Jersey 07078</B></FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>(201) 478-5552</B></FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;(973) 520-2550</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">(Name, address, telephone
  number,</FONT>&nbsp;</P></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(With copies to)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">including area code,
  of agent for service)</FONT>&nbsp;</P></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Indicate by check
  mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,
  or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller
  reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 20%; padding-left: 0.1in; text-align: center; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">Large accelerated filer&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></FONT></TD>
      <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Accelerated filer&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></FONT></TD>
      <TD STYLE="width: 20%">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Non-accelerated filer&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Do not check if a smaller reporting
  company)</P></TD>
      <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Smaller reporting company&nbsp;<FONT STYLE="font-family: Wingdings">&yacute;</FONT></FONT></TD>
      <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">&yacute;</FONT></FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If an emerging growth
  company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any
  new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CALCULATION
  OF REGISTRATION FEE</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-top: Black 2.5pt double; border-bottom: Black 1pt solid; text-align: center; width: 21%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title of securities</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be registered</B></FONT></TD>
      <TD STYLE="border-top: Black 2.5pt double; border-bottom: Black 1pt solid; text-align: center; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount to be</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>registered (1)</B></FONT></TD>
      <TD STYLE="border-top: Black 2.5pt double; border-bottom: Black 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>maximum</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>offering price</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>per share (2)</B></FONT></TD>
      <TD STYLE="border-top: Black 2.5pt double; border-bottom: Black 1pt solid; text-align: center; width: 21%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>maximum</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>aggregate offering</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>price (2)</B></FONT></TD>
      <TD STYLE="border-top: Black 2.5pt double; border-bottom: Black 1pt solid; text-align: center; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount of</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>registration fee</B></FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 10pt">Common Stock, $0.0001 par value per share</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">2,000,000</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">$2.96</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">$5,920,000</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">$690.00</FONT></TD></TR>
  </TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;(1)</P></TD><TD STYLE="text-align: justify">2,000,000 shares of common stock, $0.0001 par value per share (&ldquo;Common Stock&rdquo;), of
  ADMA Biologics, Inc. (the &ldquo;Registrant&rdquo;) which may be offered or issued pursuant to the Amended and Restated ADMA Biologics,
  Inc. 2014 Omnibus Incentive Compensation Plan (the &ldquo;2014 Plan&rdquo;), are registered on this Form S-8. 1,600,000 shares
  of Common Stock which may be offered or issued pursuant to the 2014 Plan were previously registered on Form S-8 (File No. 333-204590)
  filed on May 29, 2015. In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the &ldquo;Securities
  Act&rdquo;), this Registration Statement on Form S-8 also covers an indeterminate number of shares of Common Stock which may be
  offered or issued to prevent dilution resulting from adjustments as a result of stock dividends, stock splits, reverse stock splits,
  recapitalizations, reclassifications, mergers, split-ups, reorganizations, consolidations and other capital adjustments.</TD></TR></TABLE>
  
  <P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) and (h).
  The proposed maximum offering price per share, proposed maximum aggregate offering price and the amount of the registration fee
  are based on the average of the high and low prices of Registrant&rsquo;s Common Stock as reported on the Nasdaq Capital Market
  on August 14, 2017. Pursuant to General Instruction E of Form S-8, the registration fee is calculated with respect to the additional
  securities registered on this Form S-8 only.</TD></TR></TABLE>
  
  <P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>
  
  <P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; font: italic 8pt Times New Roman, Times, Serif; text-align: right"></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">INCORPORATION
  BY REFERENCE</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
  General Instruction E to Form S-8, the contents of the Registration Statement filed by ADMA Biologics, Inc. (the &ldquo;Registrant&rdquo;)
  with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) (File No. 333-204590), with respect to securities offered
  pursuant to the Registrant&rsquo;s Stock Incentive Plan are hereby incorporated by reference.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents
  previously filed by the Registrant with the Commission are incorporated herein by reference and shall be deemed to be a part hereof:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  Registrant&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Commission on February 24, 2017
  (including the portions of the Registrant&rsquo;s Proxy Statement on Schedule 14A, filed on April 26, 2017, as supplemented on
  May 10, 2017, incorporated by reference therein);</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  Registrant&rsquo;s Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2017 and June 30, 2017, filed with the
  Commission on May 12, 2017 and August 11, 2017, respectively;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  Registrant&rsquo;s Current Reports on Form 8-K filed with the Commission on January 23, 2017, February 17, 2017, May 10, 2017,
  May 25, 2017, May 30, 2017, June 9, 2017, June 12, 2017 (as amended on July 28, 2017) and June 27, 2017 and July 31, 2017 (provided
  that any portions of such reports that are deemed furnished and not filed pursuant to instructions to Form 8-K shall not be incorporated
  by reference into this Registration Statement on Form S-8 (this &ldquo;Registration Statement&rdquo;)); and</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  description of Common Stock set forth in the Registrant&rsquo;s Registration Statement on Form 8-A12B filed with the Commission
  on November 5, 2014 pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
  including any amendment or report filed for the purpose of updating such description.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, all documents
  that the Registrant files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the effective date
  of this Registration Statement (except for any portions of the Registrant&rsquo;s Current Reports on Form 8-K furnished pursuant
  to Item 2.02 or Item 7.01 thereof and any corresponding exhibits thereto not filed with the Commission), but prior to the filing
  of a post-effective amendment to this Registration Statement indicating that all securities offered hereby have been sold or which
  deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement
  and to be a part hereof from the date of filing such documents.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this
  Registration Statement, any document or statement contained in a document incorporated or deemed to be incorporated by reference
  herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently
  filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such document or statement
  in such document. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute
  a part of this Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; font: italic 8pt Times New Roman, Times, Serif; text-align: right"></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBITS</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 11%; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>EXHIBIT</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: left">&nbsp;</TD>
      <TD STYLE="width: 87%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>NUMBER</B></FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt"><B>DESCRIPTION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Opinion of DLA Piper LLP (US), counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement (filed herewith).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">10.1&dagger;*</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan.</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consent of CohnReznick LLP, the Registrant&rsquo;s
          Independent Registered Public Accounting Firm (filed herewith).</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power of Attorney (included on
  signature page).&nbsp;</P></TD></TR>
  </TABLE>
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-transform: uppercase; text-align: left">&nbsp;</P>
  
  <P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">*
  <B STYLE="font-style: normal; font-weight: normal">Filed herewith.</B></P>
  
  <P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">&dagger;
  Management compensatory plan, contract or arrangement.&nbsp;</FONT></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; font: italic 8pt Times New Roman, Times, Serif; text-align: right"></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SIGNATURES</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
  of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all
  of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in the City of Ramsey, State of New Jersey, on this 18<SUP>th</SUP> day of August, 2017.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD COLSPAN="2">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ADMA Biologics, Inc.</B></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Registrant)</P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 51%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-size: 10pt">By:&nbsp;</FONT></TD>
      <TD STYLE="width: 46%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">/s/ Adam S. Grossman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Name: Adam S. Grossman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Title: President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <!-- Field: Page; Sequence: 4 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; font: italic 8pt Times New Roman, Times, Serif; text-align: right"></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">KNOW BY ALL MEN BY
  THESE PRESENTS, that each person whose signature appears below constitutes and appoints Adam S. Grossman and Brian Lenz, and each
  of them, the undersigned&rsquo;s true and lawful attorneys-in-fact and agents, with full power of substitution and revocation,
  for and in the undersigned&rsquo;s name, place and stead, in any and all capacities, to sign any and all amendments (including
  post-effective amendments) to this Registration Statement on Form S-8 (this &ldquo;Registration Statement&rdquo;) and any registration
  statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and to
  file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said
  attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite
  and necessary to be done, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratify and
  confirming all that said attorneys-in-fact and agents or any of them, or their or his substitutes, may lawfully do or cause to
  be done by virtue thereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
  of the Securities Act, this Registration Statement has been signed below by the following persons on behalf of the Registrant and
  in the capacities indicated on the date listed below.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR>
      <TD STYLE="vertical-align: top; width: 40%; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Signature</B></FONT></TD>
      <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 35%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Capacity</B></FONT></TD>
      <TD STYLE="width: 2%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 21%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Adam S. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18, 2017</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;Adam S. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Brian Lenz</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Vice President and Chief Financial Officer</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18, 2017</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;Brian Lenz</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">(Principal Financial Officer and Principal Accounting Officer)</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Steven A. Elms</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors&nbsp; </FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18, 2017</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;Steven A. Elms</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Dr. Jerrold B. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Vice Chairman of the Board of Directors</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18, 2017</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;Dr. Jerrold B. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Bryant E. Fong</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18, 2017</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;Bryant E. Fong</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Dov A. Goldstein, M.D.</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18, 2017</TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify">&nbsp;&nbsp;Dov A. Goldstein, M.D.</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  </TABLE>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
  <TR>
      <TD STYLE="vertical-align: top; width: 40%; border-bottom: Black 1pt solid">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Lawrence P. Guiheen</P></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify; width: 2%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left; width: 35%">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Director</P></TD>
      <TD STYLE="width: 2%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 21%; text-align: center">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">August 18,
  2017</P></TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;Lawrence P. Guiheen</P></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P></TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid">/s/ Eric I. Richman</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">Director</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18,
  2017</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;Eric I. Richman</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P></TD>
      </TR>
  <TR>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid">/s/ Dr. Bernhard Ehmer</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">Director</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">August 18,
  2017</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;Dr. Bernhard Ehmer</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      </TR>
  </TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0"></P>
  
  <!-- Field: Page; Sequence: 5 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; font: italic 8pt Times New Roman, Times, Serif; text-align: right"></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT
  INDEX</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 11%; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>EXHIBIT</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: left">&nbsp;</TD>
      <TD STYLE="width: 87%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>NUMBER</B></FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt"><B>DESCRIPTION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Opinion of DLA Piper LLP (US), counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement (filed herewith).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">10.1&dagger;*</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan.</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consent of CohnReznick LLP, the Registrant&rsquo;s
          Independent Registered Public Accounting Firm (filed herewith).</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power of Attorney (included on
  signature page).&nbsp;</P></TD></TR>
  </TABLE>
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-transform: uppercase; text-align: left">&nbsp;</P>
  
  <P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">*
  <FONT STYLE="font-weight: normal; font-style: normal">Filed herewith.</FONT></P>
  
  <P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-weight: normal; font-style: normal">&dagger;
  Management compensatory plan, contract or arrangement.&nbsp;</FONT></P>
  
  <P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "e616485_s8-adma.htm", "secsgml_size_bytes": 50836}]
metadata_filer: {"company-data": {"conformed-name": "ADMA BIOLOGICS, INC.", "cik": "0001368514", "assigned-sic": "2836", "irs-number": "562590442", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-220058", "film-number": "171041602"}, "business-address": {"street1": "C/O ADMA BIOLOGICS, INC.", "street2": "465 STATE ROUTE 17", "city": "RAMSEY", "state": "NJ", "zip": "07446", "phone": "(201) 478-5552"}, "mail-address": {"street1": "C/O ADMA BIOLOGICS, INC.", "street2": "465 STATE ROUTE 17", "city": "RAMSEY", "state": "NJ", "zip": "07446"}, "former-company": {"former-conformed-name": "R&R ACQUISITION VI, INC", "date-changed": "20060707"}}
text: As filed with the Securities and Exchange
  Commission on August 18, 2017
  Registration No. 333-
  UNITED
  STATES
  SECURITIES
  AND EXCHANGE COMMISSION
  WASHINGTON,
  D.C. 20549
  FORM S-8
  REGISTRATION
  STATEMENT
  UNDER
  THE SECURITIES
  ACT OF 1933
  ADMA BIOLOGICS, INC.
  (Exact name of registrant as specified in
  its charter)
  Delaware
  56-2590442
  (State or other jurisdiction of
  (I.R.S. Employer Identification No.)
  incorporation or organization)
  465 State Route 17
  Ramsey, New Jersey
  07446
  (Address of Principal Executive Offices)
  (Zip Code)
  AMENDED AND RESTATED ADMA BIOLOGICS,
  INC. 2014 OMNIBUS INCENTIVE COMPENSATION PLAN
  (Full title of the plan)
  Adam S. Grossman
  President and Chief Executive Officer
  David C. Schwartz, Esq.
  ADMA Biologics, Inc.
  DLA Piper LLP (US)
  465 State Route 17
  51 John F. Kennedy Parkway, Suite 120
  Ramsey, New Jersey 07446
  Short Hills, New Jersey 07078
  (201) 478-5552
  (973) 520-2550
  (Name, address, telephone
  number,
  (With copies to)
  including area code,
  of agent for service)
  Indicate by check
  mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,
  or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller
  reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
  Large accelerated filer
  o
  Accelerated filer
  o
  Non-accelerated filer
  o
  (Do not check if a smaller reporting
  company)
  Smaller reporting company
  ý
  Emerging growth company
  ý
  If an emerging growth
  company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any
  new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
  o
  CALCULATION
  OF REGISTRATION FEE
  Title of securities
  to be registered
  Amount to be
  registered (1)
  Proposed
  maximum
  offering price
  per share (2)
  Proposed
  maximum
  aggregate offering
  price (2)
  Amount of
  registration fee
  Common Stock, $0.0001 par value per share
  2,000,000
  $2.96
  $5,920,000
  $690.00
  (1)
  2,000,000 shares of common stock, $0.0001 par value per share ("Common Stock"), of
  ADMA Biologics, Inc. (the "Registrant") which may be offered or issued pursuant to the Amended and Restated ADMA Biologics,
  Inc. 2014 Omnibus Incentive Compensation Plan (the "2014 Plan"), are registered on this Form S-8. 1,600,000 shares
  of Common Stock which may be offered or issued pursuant to the 2014 Plan were previously registered on Form S-8 (File No. 333-204590)
  filed on May 29, 2015. In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the "Securities
  Act"), this Registration Statement on Form S-8 also covers an indeterminate number of shares of Common Stock which may be
  offered or issued to prevent dilution resulting from adjustments as a result of stock dividends, stock splits, reverse stock splits,
  recapitalizations, reclassifications, mergers, split-ups, reorganizations, consolidations and other capital adjustments.
  (2)
  Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) and (h).
  The proposed maximum offering price per share, proposed maximum aggregate offering price and the amount of the registration fee
  are based on the average of the high and low prices of Registrant's Common Stock as reported on the Nasdaq Capital Market
  on August 14, 2017. Pursuant to General Instruction E of Form S-8, the registration fee is calculated with respect to the additional
  securities registered on this Form S-8 only.
  INCORPORATION
  BY REFERENCE
  In accordance with
  General Instruction E to Form S-8, the contents of the Registration Statement filed by ADMA Biologics, Inc. (the "Registrant")
  with the Securities and Exchange Commission (the "Commission") (File No. 333-204590), with respect to securities offered
  pursuant to the Registrant's Stock Incentive Plan are hereby incorporated by reference.
  The following documents
  previously filed by the Registrant with the Commission are incorporated herein by reference and shall be deemed to be a part hereof:
  (1)       The
  Registrant's Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Commission on February 24, 2017
  (including the portions of the Registrant's Proxy Statement on Schedule 14A, filed on April 26, 2017, as supplemented on
  May 10, 2017, incorporated by reference therein);
  (2)       The
  Registrant's Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2017 and June 30, 2017, filed with the
  Commission on May 12, 2017 and August 11, 2017, respectively;
  (3)       The
  Registrant's Current Reports on Form 8-K filed with the Commission on January 23, 2017, February 17, 2017, May 10, 2017,
  May 25, 2017, May 30, 2017, June 9, 2017, June 12, 2017 (as amended on July 28, 2017) and June 27, 2017 and July 31, 2017 (provided
  that any portions of such reports that are deemed furnished and not filed pursuant to instructions to Form 8-K shall not be incorporated
  by reference into this Registration Statement on Form S-8 (this "Registration Statement")); and
  (4)       The
  description of Common Stock set forth in the Registrant's Registration Statement on Form 8-A12B filed with the Commission
  on November 5, 2014 pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
  including any amendment or report filed for the purpose of updating such description.
  In addition, all documents
  that the Registrant files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the effective date
  of this Registration Statement (except for any portions of the Registrant's Current Reports on Form 8-K furnished pursuant
  to Item 2.02 or Item 7.01 thereof and any corresponding exhibits thereto not filed with the Commission), but prior to the filing
  of a post-effective amendment to this Registration Statement indicating that all securities offered hereby have been sold or which
  deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement
  and to be a part hereof from the date of filing such documents.
  For purposes of this
  Registration Statement, any document or statement contained in a document incorporated or deemed to be incorporated by reference
  herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently
  filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such document or statement
  in such document. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute
  a part of this Registration Statement.
  EXHIBITS
  EXHIBIT
  NUMBER
  DESCRIPTION
  5.1*
  Opinion of DLA Piper LLP (US), counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement (filed herewith).
  10.1†*
  Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan.
  23.1*
  Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).
  23.2*
  Consent of CohnReznick LLP, the Registrant's
          Independent Registered Public Accounting Firm (filed herewith).
  24.1*
  Power of Attorney (included on
  signature page).
  *
  Filed herewith.
  †
  Management compensatory plan, contract or arrangement.
  SIGNATURES
  Pursuant to the requirements
  of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all
  of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in the City of Ramsey, State of New Jersey, on this 18
  th
  day of August, 2017.
  ADMA Biologics, Inc.
  (Registrant)
  By:
  /s/ Adam S. Grossman
  Name: Adam S. Grossman
  Title: President and Chief Executive Officer
  KNOW BY ALL MEN BY
  THESE PRESENTS, that each person whose signature appears below constitutes and appoints Adam S. Grossman and Brian Lenz, and each
  of them, the undersigned's true and lawful attorneys-in-fact and agents, with full power of substitution and revocation,
  for and in the undersigned's name, place and stead, in any and all capacities, to sign any and all amendments (including
  post-effective amendments) to this Registration Statement on Form S-8 (this "Registration Statement") and any registration
  statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the "Securities Act"), and to
  file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said
  attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite
  and necessary to be done, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratify and
  confirming all that said attorneys-in-fact and agents or any of them, or their or his substitutes, may lawfully do or cause to
  be done by virtue thereof.
  Pursuant to the requirements
  of the Securities Act, this Registration Statement has been signed below by the following persons on behalf of the Registrant and
  in the capacities indicated on the date listed below.
  Signature
  Capacity
  Date
  /s/ Adam S. Grossman
  President and Chief Executive Officer
  August 18, 2017
  Adam S. Grossman
  (Principal Executive Officer)
  /s/ Brian Lenz
  Vice President and Chief Financial Officer
  August 18, 2017
  Brian Lenz
  (Principal Financial Officer and Principal Accounting Officer)
  /s/ Steven A. Elms
  Chairman of the Board of Directors
  August 18, 2017
  Steven A. Elms
  /s/ Dr. Jerrold B. Grossman
  Vice Chairman of the Board of Directors
  August 18, 2017
  Dr. Jerrold B. Grossman
  /s/ Bryant E. Fong
  Director
  August 18, 2017
  Bryant E. Fong
  /s/ Dov A. Goldstein, M.D.
  Director
  August 18, 2017
  Dov A. Goldstein, M.D.
  /s/ Lawrence P. Guiheen
  Director
  August 18,
  2017
  Lawrence P. Guiheen
  /s/ Eric I. Richman
  Director
  August 18,
  2017
  Eric I. Richman
  /s/ Dr. Bernhard Ehmer
  Director
  August 18,
  2017
  Dr. Bernhard Ehmer
  EXHIBIT
  INDEX
  EXHIBIT
  NUMBER
  DESCRIPTION
  5.1*
  Opinion of DLA Piper LLP (US), counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement (filed herewith).
  10.1†*
  Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan.
  23.1*
  Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).
  23.2*
  Consent of CohnReznick LLP, the Registrant's
          Independent Registered Public Accounting Firm (filed herewith).
  24.1*
  Power of Attorney (included on
  signature page).
  *
  Filed herewith.
  †
  Management compensatory plan, contract or arrangement.